To view the article, click here.
The article “Eight Questions With Darius Moshfeghi” by Scott Cousins, MD, and Darius M. Moshfeghi, MD, which was published in the February 2017 issue of Ophthalmic Surgery, Lasers and Imaging Retina (volume 48, issue 2, pp. 191–192), has been amended to include factual corrections. An error was identified subsequent to its original publication. The article stated that the manufacturer of the drug, Elamipretide, was Stealth Biotherapeutics (Auburndale, MA), instead of Stealth BioTherapeutics (Newton, MA). Additionally, the article stated that preliminary phase 1 trial results for Elamipretide would be available this summer; however, trial results are expected early next year. The online article and its erratum are considered the version of record.